Scale -

  • Revenue is 407 Rs Cr; Annual Growth is 18 %; Continuous Growth over 3 years; 5 Year CAGR is 10 %
  • Ebitda is 151 Rs Cr; Annual Growth is 19 %; Continuous Growth over 3 years; 5 Year CAGR is 17 %
  • PBT is 28.34 Rs Cr; Annual Growth is 17 %; 5 Year CAGR is 17 %
  • PAT is 77.51 Rs Cr; Annual Growth is 15 %; Continuous Growth over 3 years; 5 Year CAGR is 17 %

Profitability -

  • PBDIT Margin is 36.95 %; Continuous Growth over 3 years; in Top Quartile
  • PAT Margin is 19.03 %; in Top Quartile
  • Quarterly Ebitda Margin is 34 %; in Top Quartile

Return -

  • ROCE is 21.48 %; in Top Quartile
  • ROA is 13.78 %; in Top Quartile
  • ROE is 16.96 %; in Top Quartile
  • Asset Turnover is 79 %; in Top Quartile; Continuous Decline over 3 years

Efficiency -

  • Operating cash flow is 147 Rs Cr; Annual Growth is 56 %; Continuous Growth over 3 years; 5 Year CAGR is 26 %
  • Current Ratio is 3.43; Continuous Growth over 3 years
  • Quick Ratio is 2.97; Continuous Growth over 3 years
  • Inventory Turnover Ratio is 14.81; Continuous Growth over 3 years

Solvancy -

  • Debt/Equity is 0.01; Annual Decline is -50 %; Continuous Decline over 3 years; 5 Year CAGR is -41 %
  • Long term Debt is 1.56 Rs Cr; Annual Decline is -52 %; Continuous Decline over 3 years; 5 Year CAGR is -41 %
  • Total Debt is 3.33 Rs Cr; Annual Decline is -61 %; Continuous Decline over 3 years; 5 Year CAGR is -35 %
  • Contingent Liabilities is 5.99 Rs Cr; Annual Decline is -78 %; Continuous Decline over 3 years

Quality -

  • Operating cashflow/ebitda is 98 %; Annual Growth is 30 %; Continuous Growth over 3 years; in Top Quartile
  • Operating cashflow/PAT is 190 %; Annual Growth is 35 %; in Top Quartile
  • Current Tax/PAT is 34 %; in Top Quartile
  • Change in Inventories/Total Expenses is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector
Major Subsidiaries/Associates
Key Clients

Products

Products
Product details

Operations

Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
Vimta Labs Q2 FY27 Total Income Jumps To ?114.9 Crore, Half-Year Revenue Hits ?227.8 Crore As Biologics
Read More
  • Past/current
Vimta Labs Q4 FY26 Earnings Call: Revenue Up 16.6%, EBITDA Margins at 37.6%
Read More
  • Past/current